Window Trial to Evaluate Molecular Response to PI3K Inhibition With Copanlisib in r/r Adult B-cell ALL

NCT04803123 · clinicaltrials.gov ↗

EARLY_PHASE1

Phase

TERMINATED

Status

3

Enrollment

OTHER

Sponsor class

Stopped Sponsor halted clinical development of study drug

Conditions

Leukemia, Acute Lymphocytic

Interventions

DRUG: Copanlisib

Sponsor

Dorothy Sipkins, MD, PhD

Collaborators

[object Object]